These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29910082)

  • 1. Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
    Clemente-Tomás R; Arciniegas-Perasso CA; Hervás-Hernandis JM; García-Ibor F; Ruiz-Del Río N; Duch-Samper AM
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Oct; 93(10):511-514. PubMed ID: 29910082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brimonidine-associated uveitis - a descriptive case series.
    Hopf S; Mercieca K; Pfeiffer N; Prokosch-Willing V
    BMC Ophthalmol; 2020 Dec; 20(1):489. PubMed ID: 33334316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brimonidine Induced Anterior Uveitis.
    Beltz J; Zamir E
    Ocul Immunol Inflamm; 2016; 24(2):128-33. PubMed ID: 26399160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suspected granulomatous anterior uveitis associated with brimonidine tartrate 0.2% and timolol maleate 0.5% ophthalmic solution.
    Casado A; Cabarga C; de la Fuente MA; Muñoz-Negrete FJ
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2659-60. PubMed ID: 23835755
    [No Abstract]   [Full Text] [Related]  

  • 5. Anterior uveitis as a side effect of topical brimonidine.
    Byles DB; Frith P; Salmon JF
    Am J Ophthalmol; 2000 Sep; 130(3):287-91. PubMed ID: 11020406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brimonidine-timolol fixed combination induced granulomatous inflammation of the eye.
    Carrasco MA; Schlaen BA; Zárate JO
    Int Ophthalmol; 2013 Oct; 33(5):557-60. PubMed ID: 23224363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features.
    Nguyen EV; Azar D; Papalkar D; McCluskey P
    J Glaucoma; 2008; 17(1):40-2. PubMed ID: 18303383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
    Becker HI; Walton RC; Diamant JI; Zegans ME
    Arch Ophthalmol; 2004 Jul; 122(7):1063-6. PubMed ID: 15249377
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anterior uveitis and topical brimonidine: a case report].
    Velasque L; Ducousso F; Pernod L; Vignal R; Deral V
    J Fr Ophtalmol; 2004 Dec; 27(10):1150-2. PubMed ID: 15687926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
    Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials.
    Zabriskie N; Netland PA;
    Adv Ther; 2003; 20(2):92-100. PubMed ID: 12836809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.
    Frampton JE
    Drugs Aging; 2006; 23(9):753-61. PubMed ID: 17020399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorzolamide/Timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: a 3-month comparison of efficacy, tolerability, and patient-reported measures.
    Solish AM; DeLucca PT; Cassel DA; Kolodny AH; Hustad CM; Skobieranda F
    J Glaucoma; 2004 Apr; 13(2):149-57. PubMed ID: 15097262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.
    Kóthy P; Holló G
    Int Ophthalmol; 2020 Feb; 40(2):377-383. PubMed ID: 31650353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral granulomatous uveitis in an elderly female.
    Kattige J; Konana VK; Babu K
    Indian J Ophthalmol; 2019 Sep; 67(9):1391. PubMed ID: 31436179
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension.
    Orzalesi N; Rossetti I; Bottoli A; Invernizzi T; Fumagalli E; Fogagnolo P
    Acta Ophthalmol Scand Suppl; 2002; 236():55. PubMed ID: 12390144
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservative-free
    Duru Z; Ozsaygili C
    Cutan Ocul Toxicol; 2020 Mar; 39(1):21-24. PubMed ID: 31615279
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
    Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior uveitis associated with latanoprost.
    Fechtner RD; Khouri AS; Zimmerman TJ; Bullock J; Feldman R; Kulkarni P; Michael AJ; Realini T; Warwar R
    Am J Ophthalmol; 1998 Jul; 126(1):37-41. PubMed ID: 9683147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.